Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3)

episode

Talking About Glaucoma (mp3) not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Talking About Glaucoma (mp3)

Procedural Pharmaceuticals in Glaucoma with Steve Sarkisian, ep 42 23 min · 06 Aug 2026

All episodes from Talking About Glaucoma (mp3) →

Report any issue

Source

Recorded07 Jun 2019

Publisherwholelottarob.com ↗

Handlerec:10254605

Show notes

The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals…and we’re Talking About Glaucoma.Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts and tell your friends about it, so that it can reach more listeners. Drop me a line at [email protected] with your show ideas.—————————————————————————Selected links:https://aeriepharma.com/https://clinicaltrials.gov/ct2/show/NCT02246764—————————————————————————Production information:This episode was recorded March 2019 during the Annual Meeting of the American Glaucoma Society in San Francisco using two Shure SM58 microphones with a Marantz PMD661 digital recorder. Mixing and sound levelling were completed June 2019 on an iMac using Hindenberg Journalist Pro software. Narration was overdubbed using a Blue Yeti Microphone.Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.Robert M Schertzer, MD, MEd, [email protected] - http://twitter.com/robschertzeror http://iguy.tv/twitterBlog - http://wholelottarob.comor http://iguy.tv/blogFacebook - http://facebook.com/talkingaboutglaucomaOffice website - http://westcoastglaucoma.comor http://iguy.tv/officeTheme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr© 2019 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC—————————————————————————Today’s guest:Richard A. Lewis, MDSacramento Eye Consultants1515 River Park Drive, Suite 100, Sacramento, CA 95815Tel: [email protected]://www.sacramentoeyeconsultants.com/sacramento/our-doctors/richard-a-lewis-md.htm—————————————————————————

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.